A single-injection protein kinase a-directed antisense treatment to inhibit tumour growth

Nature Medicine

Volumn 1, Issue 6, 1995, Pages 528-532

  Nesterova, Maria ^a   Cho Chung, Yoon S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; DRUG ANALYSIS; DRUG DEVELOPMENT; ENZYME SUBUNIT; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH;

ANIMAL; BASE SEQUENCE; CARCINOMA; CELL TRANSFORMATION, VIRAL; COLONIC NEOPLASMS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SCREENING ASSAYS, ANTITUMOR; GENE THERAPY; HUMAN; INJECTIONS, SUBCUTANEOUS; ISOENZYMES; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE;

EID: 0029050664     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0695-528     Document Type: Article

References (31)

1. Krebs, E.G. Protein kinase. Curr. Topics Cell Regul. 5, 99-133 (1972).
2. Lohmann, S.M. and Walter, U. Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases, in Advances in Cyclic Nucleotide and Protein Phosphorylation Research, vol. 18, 63-117 (Raven, New York, 1984).
3. Cho-Chung, Y.S. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy [Perspec-tives in cancer research]. Cancer Res. 50, 7093-7100 (1990).
4. Beebe, S.J. and Corbin, J.D. Cyclic nucleotide-dependent protein kinases, in The Enzymes: Control by Phosphorylation, vol. 17, part A, 43-111 (Academic, New York, 1986).
5. McKnight, G.S. et al. Analysis of the cAMP-dependent protein kinase system using molecular genetic approaches. Recent Prog. Horm. Res. 44, 307-335 (1988).
6. Levy, F.O. et al. Molecular cloning, complementary deoxyribonucleic acid structure and predicted full-length amino acid sequence of the hormone-inducible regulatory subunit of 3', 5'cyclic adenosine monophosphate-dependent protein kinase from human testis. Uolec. Endocrinol. 2, 1364-1373 (1988).
7. Uhler, M.D. et al. Isolation of cDNA clones coding for the catalytic subunit of mouse cAMP-dependent protein kinase. Proc. natn. Acad. Sci. U.S.A. 83, 1300-1304 (1986).
8. Uhler, M.D., Chrivia, J.C. and McKnight, G.S. Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. J. biol. Chem. 261, 15360-15363 (1986).
9. Showers, M.O. and Maurer, R.A. A cloned bovine cDNA encodes an alternate form of the catalytic subunit of cAMP-dependent protein kinase. J. biol. Chem. 261, 16288-16291 (1986).
10. Beebe, S.J. et al Molecular cloning of a unique tissue-specific protein kinase (Cy) from human testis—representing a third isoform for the catalytic subunit of the cAMP-dependent protein kinase. Molec. Endocrinol 4, 465-475 (1990).
11. Oyen, O. etal. A unique mRNA species for a regulatory subunit of cAMP-dependent protein kinase is specifically induced in haploid germ cells. FEBS Lett. 229, 391-394 (1988).
12. Clegg, C.H., Cadd, G.G. and McKnight, G.S. Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase. Proc. natn. Acad. Sci. US.A. 85, 3703-3707 (1988).
13. Cadd, G.G., Uhler, M.D. and McKnight, G.S. Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides. J. biol. Chem. 265, 19502-19506 (1990).
14. Kapoor, C.L. and Cho-Chung, Y.S. Compartmentalization of regulatory subunits of cyclic adenosine 3', 5'-monophosphate-dependent protein kinases in MCP-7 human breast cancer cells. Cancer Res. 43, 295-302 (1983).
15. Nigg, E.A., Schafer, G., Hilz, H. and Eppenberger, H.M. Cyclic-AMP-dependent protein kinase type II is associated with the golgi complex and with centro- somes. Cell 41, 1039-1051 (1985).
16. Taylor, S.S. et al cAMP-dependent protein kinase: Prototype for a family of enzymes. FASEB J. 2, 2677-2685 (1988).
17. Yokozaki, H. et al An antisense ollgodeoxynucleotide that depletes RIa subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res. 53, 868-872 (1993).
18. Tortora, G, Yokozaki, H., Pepe, S., Clair, T. and Cho-Chung, Y.S. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynu- cleotide of cAMP-dependent protein kinase. Proc. natn. Acad. Sci. US.A. 88, 2011-2015 (1991).
19. Sandberg, M., Tasken, K., 0yen, O., Hansson, V, and Jahnsen, T. Molecular cloning, cDNA structure and deduced amino acid sequence for A type I regulatory subunit of cAMP-dependent protein kinase from human testis. Biochem. biophys. Res. Commun. 149, 939-945 (1987).
20. Tortora, G., Clair, T. and Cho-Chung, Y.S. An antisense oligodeoxynu- cleotide targeted against the type RIIp regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Proc. natn. Acad. Sci. U.S.A. 87, 705-708 (1990).
21. Rosen, O.M. and Erlichman, J. Reversible autophosphorylation of a cyclic 3', 5'-AMP-dependent protein kinase from bovine cardiac muscle. J. biol. Chem. 250, 7788-7794 (1975).
22. Rohlff, C, Clair, T. and Cho-Chung, Y.S. 8-Cl-cAMP induces truncation and down-regulation of the RIa subunit and up-regulation of the RIIe subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J. biol Chem. 268, 5774-5782 (1993).
23. Tagliaferri, P., Katsaros, D., Clair, T., Neckers, L., Robins, R.K. and Cho-Chung, Y.S, Reverse transformation of Harvey murine sarcoma virus-transformed NIH/3T3 cells by site-selective cyclic AMP analogs. J. biol Chem. 263, 409-416 (1988).
24. Connelly, P.A., Hastings, T.G. and Reimann, E.M. Identification of a ternary complex between cAMP and a trimeric form of cAMP-dependent protein kinase. J. biol Chem. 261, 2325-2330 (1986).
25. Cobb, C.E., Beth, A.H. and Corbin, J.D. Purification and characterization of an inactive form of cAMP-dependent protein kinase containing bound cAMP. J. biol Chem. 262, 16566-16574 (1987).
26. Otten, A.D., Parenteau, L.A., Doskeland, S. and McKnight G.S. Hormonal activation of gene transcription in ras-transformed NIH3T3 cells overexpressing RII„ and RIIP subunits of the cAMP-dependent protein kinase. J. biol Chem. 266, 23074-23082 (1991).
27. Nesterova, M., Budillon, A., Pepe, S., Cereseto, A. and Cho-Chung, Y.S. Introducing an autophosphorylation site mutation in the RII? regulatory subunit of cAMP-dependent protein kinase abolishes the RII0-mediated regulatory function. FASEB J, 8, A1328 (1994) (abstract).
28. Srivastava, A.K. and Stellwagen, R.H. Presence of the sites for interacting with cyclic AMP and with catalytic subunit on small fragments of protein kinase regulatory subunit. J, biol. Chem. 253, 1752-1755 (1978).
29. Wagner, R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333-335 (1994).
30. Iversen, P. In vivo studies with phosphorothioate oligonucleotides: Pharmacokinetics prologue. Anti-Cancer Drug Des. 6, 531-538 (1991).
31. Weber, W. and Hilz, H. cAMP-dependent protein kinases I and II: Divergent turnover of subunits. Biochemistry 25, 5661-5667 (1986).